Prosperity Capital Advisors’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Prosperity Capital Advisors’s Portfolio IDNA Stock Details IDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$616K	Sell	21,208 -2,804	-12%	-$81.4K	0.04%	248
2025 Q4	$629K	Sell	24,012 -502	-2%	-$12.9K	0.04%	223
2025 Q3	$579K	Buy	24,514 +2,228	+10%	+$49.3K	0.03%	259
2025 Q2	$457K	Buy	22,286 +4,798	+27%	+$96.6K	0.03%	273
2025 Q1	$349K	Buy	17,488 +3,085	+21%	+$68.9K	0.03%	274
2024 Q4	$326K	Sell	14,403 -288	-2%	-$6.92K	0.03%	271
2024 Q3	$362K	Buy	14,691 +1,058	+8%	+$25.8K	0.03%	249
2024 Q2	$315K	Buy	13,633 +1,792	+15%	+$41.9K	0.03%	240
2024 Q1	$285K	Buy	11,841 +182	+2%	+$4.27K	0.03%	271
2023 Q4	$268K	Buy	+11,659	New	+$234K	0.03%	210

Other funds holding IDNA

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

PGA

Portland Global Advisors Portland, Maine $938M AUM 13.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

CCA

Clearwater Capital Advisors Hoffman Estates, Illinois $1.24B AUM 15.23% 1-Year Est. Return

Prosperity Capital Advisors's IDNA Position: Q1 2026 in Review

Prosperity Capital Advisors reduced its iShares Genomics Immunology and Healthcare ETF (IDNA) stake by 12% in Q1 2026, selling an estimated $81.4K and leaving 21,208 shares worth $616K. The position accounts for 0.04% of the portfolio, ranked #248.

Prosperity Capital Advisors first reported a position in IDNA in Q4 2023 and has held it in 10 quarters since. The position peaked at $629K in Q4 2025. 60 funds tracked by Wall St. Rank hold IDNA as of Q1 2026.

Prosperity Capital Advisors held 21,208 shares of iShares Genomics Immunology and Healthcare ETF worth $616K as of Q1 2026.
Prosperity Capital Advisors sold 2,804 iShares Genomics Immunology and Healthcare ETF shares in Q1 2026, an estimated $81.4K.
iShares Genomics Immunology and Healthcare ETF made up 0.04% of Prosperity Capital Advisors's portfolio in Q1 2026, its #248 holding.
Prosperity Capital Advisors first reported a position in iShares Genomics Immunology and Healthcare ETF in Q4 2023 and has held it in 10 quarters since.
Prosperity Capital Advisors's iShares Genomics Immunology and Healthcare ETF position peaked at $629K in Q4 2025.
60 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q1 2026.

Based on Prosperity Capital Advisors's 13F filing for Q1 2026, filed 9 Apr 2026.